Gene · 2648
Papers3,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Publisher Correction: NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation. | Oncogene | 2025 | 40983637 | PubTator, text mining | PubMed |
| Reversion of aortic valve cells calcification by activation of Notch signalling via histone acetylation induction. | Signal Transduct Target Ther | 2025 | 40962819 | PubTator, text mining | PubMed |
| The MLLT3 YEATS domain is a dual reader of histone marks (H3K9/18/27ac/cr) and ncRNA (7SK), linking epigenetic and RNA signaling to regulate hematopoiesis. | bioRxiv | 2025 | 40950097 | PubTator, text mining | PubMed |
| Targeting the Epigenetic Remodeler GCN5 Prevents Vascular Oxidative Stress and Endothelial Dysfunction in Obesity: Insights in Patients with Cardiometabolic Disease. | High Blood Press Cardiovasc Prev | 2025 | 40924347 | PubTator, text mining | PubMed |
| Regulation of PPAR-γ coactivator-1α and its implication in mitochondrial function and neurodegenerative diseases. | Ageing Res Rev | 2025 | 40907612 | PubTator, text mining | PubMed |
| SOX2 drives esophageal squamous carcinoma by reprogramming lipid metabolism and histone acetylation landscape. | Nat Commun | 2025 | 40897722 | PubTator, text mining | PubMed |
| NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation. | Oncogene | 2025 | 40890513 | PubTator, text mining | PubMed |
| Molecular mechanisms of mitochondrial quality control. | Transl Neurodegener | 2025 | 40887660 | PubTator, text mining | PubMed |
| Histone H3K27 acetylation mediated by KAT8 maintains antiviral trained immunity in shrimp induced by inactivated white spot syndrome virus. | Commun Biol | 2025 | 40885857 | PubTator, text mining | PubMed |
| Retraction: Targeting gut microbiota-derived butyrate improves hepatic gluconeogenesis through the cAMP-PKA-GCN5 pathway in late pregnant sows. | Food Funct | 2025 | 40878217 | PubTator, text mining | PubMed |
| Cytotoxicity of activator expression in CRISPR-based transcriptional activation systems. | Nat Commun | 2025 | 40877321 | PubTator, text mining | PubMed |
| Correction: Liu et al. GCN5 Potentiates Glioma Proliferation and Invasion via STAT3 and AKT Signaling Pathways. Int. J. Mol. Sci. 2015, 16, 21897-21910. | Int J Mol Sci | 2025 | 40869432 | PubTator, text mining | PubMed |
| Extracellular vesicle-derived lncRNA-GC1 serves as a novel biomarker for predicting and monitoring the immunotherapeutic outcomes of patients with gastric cancer. | BMC Med | 2025 | 40866962 | PubTator, text mining | PubMed |
| Succinylation - encoded metabolic codes: cracking the molecular logic of cellular adaptation. | Int J Surg | 2025 | 40865948 | PubTator, text mining | PubMed |
| Crotonylation of IDH1 alleviates MASLD progression by enhancing the TCA cycle. | Nat Commun | 2025 | 40858572 | PubTator, text mining | PubMed |
| H4K79 and H4K91 histone lactylation, newly identified lactylation sites enriched in breast cancer. | J Exp Clin Cancer Res | 2025 | 40849487 | PubTator, text mining | PubMed |
| Integrative Mendelian randomization and multi-omics analysis identifies anti-allergic drug targets associated with cardiovascular disease risk. | Sci Rep | 2025 | 40841572 | PubTator, text mining | PubMed |
| Identification of hypoxia-related diagnostic biomarkers and immune signatures in diminished ovarian reserve. | Front Genet | 2025 | 40832468 | PubTator, text mining | PubMed |
| Curcumin inhibits ferroptosis through dessuccinylation of SIRT5-associated ACSL4 protein, and plays a chondroprotective role in osteoarthritis. | PLoS One | 2025 | 40825027 | PubTator, text mining | PubMed |
| ACSS2 coupled with KAT7 regulates histone β-hydroxybutyrylation to enhance transcription. | Sci Adv | 2025 | 40815653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2648/papers?page=8